Navigation Links
Producing Vaccines from genetically modified crops

The consortium, called Pharma-Planta, wants to produce vaccines and other treatments for major //diseases, such as HIV/Aids, rabies and TB and they hope to start clinical trials by the year 2009. The project's aim is to focus on areas that will be of greatest benefit to developing nations where they feel that access to most vaccines is very poor at the same time keeping in mind that human health and the environment are protected.

The first product, possibly grown in maize, is likely to be an antibody that can be used to block HIV transmission and it has been decided to incorporate it into a microbicidal cream that could be used in the vagina. The second product will probably to be a post-bite vaccine for rabies, which is still a significant killer in Africa and southeast Asia.

Researchers at Pharma –Planta say that the plants will be grown in pharmaceutical production units on dedicated land , isolated from food crops. Thirty-nine labs in 11 European countries will work together, with input from researchers in South Africa, where HIV/Aids is a major public health issue. Scientific co-ordinators at Pharma –Planta say many commercial companies have withdrawn from vaccine development and production because of low economic returns ,however they say that Pharma-Planta hopes the technology it will develop over the course of its initial five years of funding will eventually boost the global supply of treatments.

Current methods used include genetic modification of human cells and microorganisms such as bacteria. These techniques are labour intensive, expensive and often only produce relatively small amounts of pharmaceuticals. Researchers at Pharma – Planta say that plants are inexpensive to grow as well as to engineer them to contain a gene for a pharmaceutical product and most importantly they could produce large quantities of drugs or vaccines at low cost. The project has yet to decide which plants to use but some of the plants mos t likely to be used include tobacco, maize, potatoes and tomatoes. Although Pharma- Planta claims to maintain and follow the ideal conditions and procedures for their project others are of the opinion that Pharma- Planta’s research could have widespread negative impacts and also suggest that a clear set of criteria must be established to ensure that human health and the environment are protected

'"/>




Related medicine news :

1. A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells
2. New Technique Developed By Scientists For Producing Stem Cells without Damaging Embryos
3. Producing More Drugs For Lethal Diseases Is Not The Answer
4. A Combined Research for Producing Chlamydia Vaccine Begins
5. Height of Liberation – Lesbians, No Less in Producing Babies (read Daughters
6. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
7. New Anthrax Vaccines Will Take time
8. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
9. Health and Human Services stockpiles 20 million bird flu Vaccines
10. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
11. Oral Edible vaccine for Allergy Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, ... is painful for her. "This is why the co-inventor and I have designed a ... They then created a prototype of the patent-pending AV-AIR, a device that serves as ...
(Date:12/7/2016)... ... XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s ... Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition similar ... the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Facial plastic ... this holiday season by donating a portion of proceeds to two local organizations: North ... Chicago Animal Control & Friends is a team of authorized and trained volunteers ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live From won ... year’s best in pioneering, inventive, and ultimately successful projects undertaken by the media ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite ... Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on their ... experience. , BOC Global Events & Training Group is a professional event and ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 Homozygous Familial Hypercholesterolemia (HoFH) ... Global Markets Direct,s latest Pharmaceutical and ... (HoFH) – Pipeline Review, H2 2016, provides ... (HoFH) (Metabolic Disorders) pipeline landscape. Homozygous ... is caused due to mutation from both ...
(Date:12/6/2016)... Dec. 6, 2016 Human Vaccines Market: ... region wise and country wise analysis of the ... manufacturers of human vaccines products, raw material suppliers, ... enter the market. The report provides qualitative ... market. Qualitative analysis comprises market dynamics, trends, product ...
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million ... suffer from the epidemic of diabetes. 1 However, ... persistently elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... serious complications, including cardiovascular events. If left untreated, hyperglycemia ... and eye disease or blindness. 3 ...
Breaking Medicine Technology: